Freedom Study: Myfortic in Kidney Transplant Patients

Completed · Phase 3

Conditions studied: Kidney Transplantation

In brief

The primary objective of the study is to evaluate that 3 immunosuppressant regimens will have comparable kidney function results in kidney transplant patients.

Key facts

Study ID
NCT00101738
Run by
Novartis Pharmaceuticals
People needed
342
Starts
2003-03-01
Expected to finish
2005-05-01
Last updated by the study team
2011-01-31

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.